Active

Speak at the 2023 MIT Health Science Technology Conference (April 4)

Deadline: February 9, 2023

The Startup Exchange team is looking for 10 startups to present their technology/companies during the Startup Lightning Talks and participate at the lunch Exhibit on April 4, at the 2023 MIT Health Science Technology Conference.

Format: Startup Lightning Talks around noon (5 mins each), followed by Startup Lunch Exhibit (1 hr).

Focus: technology, tools, products relevant to biopharma and healthcare, in drug discovery, development, screening, efficacy testing, data analytics, biologics, and manufacturing.

Audience: ILP corporate members and MIT community.

Overview: This conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.

Please note, MIT Startup Exchange will prioritize the startups who have yet to participate in our events. 

Deadline: February 9, 2023
Posted on: January 25, 2023
Location: MIT Campus
Industry: Biopharma and Healthcare

The Startup Exchange team is looking for 10 startups to present their technology/companies during the Startup Lightning Talks and participate at the lunch Exhibit on April 4, at the 2023 MIT Health Science Technology Conference.

Format: Startup Lightning Talks around noon (5 mins each), followed by Startup Lunch Exhibit (1 hr).

Focus: technology, tools, products relevant to biopharma and healthcare, in drug discovery, development, screening, efficacy testing, data analytics, biologics, and manufacturing.

Audience: ILP corporate members and MIT community.

Overview: This conference will explore new or improved therapeutic approaches for finding cures for diseases which traditionally have been difficult to treat. This includes technologies for optimizing treatments and monitoring efficacy based on insights into cell and tissue state, circuitry, behavior, function, and responsiveness in normal and disease states, biomarker detection, better methods to predict and track efficacy, and enhanced manufacturing capabilities.

Please note, MIT Startup Exchange will prioritize the startups who have yet to participate in our events. 

APPLICATION REQUIREMENTS

- brief description of your startup's technology-based product/services & 1 compelling use case;

- brief description of current market traction (e.g., pilot, validation results, paying customers, etc.);

- one-paragraph explanation of the unique fit between the event/theme and the startup's vision, technologies, products, or services.

- speaker bio & a few words on the speaker's experience as a speaker (optionally, including a video sample);

In addition, please make sure to update your Startup Exchange profile if you have yet to do so recently. An up-to-date profile will ensure we can correctly match you with corporate requests.

  • APPLICATION REQUIREMENTS

    - brief description of your startup's technology-based product/services & 1 compelling use case;

    - brief description of current market traction (e.g., pilot, validation results, paying customers, etc.);

    - one-paragraph explanation of the unique fit between the event/theme and the startup's vision, technologies, products, or services.

    - speaker bio & a few words on the speaker's experience as a speaker (optionally, including a video sample);

    In addition, please make sure to update your Startup Exchange profile if you have yet to do so recently. An up-to-date profile will ensure we can correctly match you with corporate requests.


Disclaimer:  MIT Startup Exchange can make introductions that ideally provide open ended discussions in order to share mutual interests and potentially create common ground that incite the parties to collaborate. MIT Startup Exchange introductions may eventually lead to mutual partnerships, but that is not in any way guaranteed by MIT, MIT Corporate Relations, MIT Industrial Liaison Program (ILP) or MIT Startup Exchange, which takes no responsibility for these outcomes and no formal part in such discussions following our introduction. MIT Startup Exchange and its activities and events are not for purposes of soliciting investment or offering securities.